Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for...
The Macau Special Administrative Region (ISAF) Pharmaceutical Administration Bur...
Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneou...
The Weill Cancer Hub East has been established to explore the “interplay” betwee...
Genmab has received approval from Japan's Ministry of Health, Labour and Welfare...
The drug, named Vykat XR, will be available to patients in the US with Prader-Wi...
The US Food and Drug Administration (FDA) will see the biggest cuts, with 19% of...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced...
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next f...
While Cassava is stopping investigations into simufilam in Alzheimer’s disease, ...
Character Biosciences has raised $93m in an oversubscribed Series B funding roun...
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral ...
MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent co...
EU member states are set to launch the EU Health Data Space Regulation for harmo...
Ensuring the highest standards in pharmaceutical logistics is crucial for patien...
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infe...
